Not intended for injection, ingestion, or topical use
Before using this medication, tell your doctor or pharmacist your medical history, especially of: low potassium blood levels (hypokalemia), gout, a certain blood disorder (polycythemia vera), a certain eye disease (Leber's disease), other vitamin/mineral deficiencies (especially folic acid and iron)
You should not take a GLP-1 if you are currently pregnant or breastfeeding
Liposomal Liquids: Designed to bypass digestive breakdown for high cellular uptake
Future therapies: Scientists are developing next-generation GLP-1 drugs that may have an even greater impact on brain health
Recent Developments: Roche - Acquisition (December 2023): Roche acquired Carmot Therapeutics, adding dual GLP-1/GIP agonist assets to its pipeline, positioning to compete with Novo Nordisk and Eli Lilly in obesity [1]